Advertisement
News
Subscribe to MDT Magazine News

Genzyme closes $265M unit sale, plans another divestiture

February 1, 2011 6:35 am | by Mass High Tech: The Journal of New England Technology | Comments

Genzyme Corp. plans to sell its pharmaceutical intermediates business to an affiliate of the International Chemical Investors Group. Today's news comes as the Cambridge biotech giant completes its $265 million cash sale of its diagnostics business to Sekisui Chemical Co, Ltd., announced...

Soligenix Appoints Kevin Horgan, MD, as Chief Medical Officer

February 1, 2011 6:32 am | by Bio-Medicine.Org | Comments

PRINCETON, N.J., Feb. 1, 2011 /- Soligenix, Inc. (OTC Bulletin Board: SNGX ) (Soligenix or the Company), a late-stage biopharmaceutical company, announced today that it has appointed Kevin Horgan, MD, as its Senior Vice President and Chief Medical Officer. Dr. Horgan is a board-certified...

TOPICS:

Quest Diagnostics Announces Pricing in Offering of Common Stock by the Company's Largest Shareholder

February 1, 2011 6:31 am | by Bio-Medicine.Org | Comments

MADISON, N.J., Feb. 1, 2011 /- Quest Diagnostics Incorporated (NYSE: DGX ) today announced the pricing of the previously announced secondary public offering of 15,377,600 shares of Quest Diagnostics common stock held by its largest stockholder, SB Holdings Capital Inc., an affiliate of...

TOPICS:
Advertisement

Biogen 4Q profit drops 21 pct as expenses rise

February 1, 2011 5:45 am | by The Associated Press | Comments

The biotechnology company Biogen Idec reported that its fourth-quarter profit tumbled 21 percent, citing on Tuesday restructuring charges and rising expenses that outweighed the sales of key drugs.The performance topped expectations on Wall Street and shares rose 3 percent..The Weston, Mass.,...

Massachusetts Sen. Brown urges medical device tax repeal

February 1, 2011 5:34 am | by Mass High Tech: The Journal of New England Technology | Comments

As Congressional Republicans ready their assault on President Barack Obama's health care reform law, Bay State Sen. Scott Brown said Monday that he would file legislation to chip away at the bill by repealing the medical device tax that he said will stymie job growth in Massachusetts.

Discovery Labs targets 3Q for Surfaxin FDA filing

February 1, 2011 4:45 am | by The Associated Press | Comments

Discovery Laboratories Inc. said Tuesday it aims to file early in the third quarter a complete response to the Food and Drug Administration for its drug Surfaxin.Surfaxin aims to prevent respiratory distress syndrome in premature infants. The Warrington, Pa., company said it believes a key...

Canada's Windsor-Essex Region Collaborates With IBM to Improve Quality of Life for Citizens

February 1, 2011 4:35 am | by IBM | Comments

The region of Windsor-Essex, Ontario, Canada, today announced that it is using social business technology from IBM (NYSE: IBM) to significantly improve the quality of life for its citizens. E-mail this page Save to del.icio.us Digg this

TOPICS:

UBM Studios Virtual Event Connects the UBM Canon Medical Device Media Group with the Medical Device Design Community

February 1, 2011 4:35 am | by Bio-Medicine.Org | Comments

CHICAGO, Feb. 1, 2011 /- UBM Canon Medical Device Media Group's MD+DI , MPMN and OrthoTec presented the " Technological Advances in Implantable Devices " virtual event on January 26, 2011 from 11 a.m. – 5 p.m. Eastern.  The event is dedicated to cutting-edge trends in the...

TOPICS:
Advertisement

CardioGenics to Continue Commercialization of its Magnetic Beads with Merck Chimie SAS

February 1, 2011 4:35 am | by Bio-Medicine.Org | Comments

MISSISSAUGA, Ontario, Feb.  1, 2011 /- CardioGenics Holdings Inc. (OTC Bulletin Board: CGNH ) announced today that CardioGenics and Merck Chimie SAS continue the commercialization process of CardioGenics' magnetic beads. Merck recently notified CardioGenics that while it is refining...

TOPICS:

CryoLife Announces Release Date and Teleconference Call Details for 2010 Fourth Quarter and Year End Financial Results

February 1, 2011 4:34 am | by Bio-Medicine.Org | Comments

ATLANTA, Feb. 1, 2011 /- CryoLife, Inc. (NYSE: CRY ), an implantable biological medical device and cardiovascular tissue processing company, announced today that 2010 fourth quarter and year end financial results will be released on Thursday, February 17, 2011.  On that day, the...

TOPICS:

CareFusion Names Kieran T. Gallahue Chairman and CEO

February 1, 2011 4:34 am | by Bio-Medicine.Org | Comments

SAN DIEGO, Feb. 1, 2011 /- CareFusion Corporation (NYSE: CFN ), a global, medical technology company, announced today the appointment of Kieran T. Gallahue as chairman and chief executive officer, succeeding David L. Schlotterbeck who previously announced plans to retire later this month....

TOPICS:

China SHESAYS Announces Preliminary Unaudited Results for FY 2010; Provides Business Outlook Update for Investors

February 1, 2011 4:34 am | by Bio-Medicine.Org | Comments

CHENGDU, China, Feb. 1, 2011 /PRNewswire-Asia-FirstCall/ -- China SHESAYS Medical Cosmetology Inc. (OTC Bulletin Board: CSAY ) ("China SHESAYS" or the "Company"), which operates a network of specialized medical cosmetology hospitals, clinics and skincare centers in Sichuan province,...

TOPICS:

BG Medicine halves IPO price

February 1, 2011 4:32 am | by Mass High Tech: The Journal of New England Technology | Comments

BG Medicine Inc. has re-priced its initial public offering at about half what it was shooting for in December, lowering its total IPO fundraise to $33.3 million, according to a regulatory filing.

TOPICS:

DALSA acquisition lets us look at the MEMS world differently

February 1, 2011 3:32 am | by I-Micronews | Comments

DALSA was acquired by Teledyne in an all cash deal for $18.25 a share for a total of $341.0 million.

Repeat MRI screening for breast cancer results in fewer false positives

January 31, 2011 9:31 pm | by EurekAlert | Comments

(Radiological Society of North America) MRI screening for breast cancer delivers consistent rates of cancer detection and fewer false-positive results over time, according to a new study.

TOPICS:

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading